Smad4 is essential for TGF-β-mediated inhibition of ERα estrogenic transcription activity, and the inhibition of Smad4 expression switches TGF-β from a repressor to an activator for ERα transactivation in breast cancer cells. This evidence concerns the gene SMAD4 and breast carcinoma.